{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "http://www.sunbio.com/#organization",
      "name": "선바이오(주)",
      "url": "http://www.sunbio.com/",
      "description": "SunBio is a biotech company developing biosimilars, biopharmaceuticals, and medicaldevices based on our proprietary technologies of pegylation. SunBio’s biosimilar product, PEG-filgrastim, has been marketed in India since 2008, and gained a marketing approval in Canada in 2018, and gained a marketingapproval in EU in 2018. Products currently under development are a treatment for xerostomia, a visco-supplement for arthritic knee, a treatment for brain stroke, and a treatment for diabetic retinopathy. SunBio offers a variety of PEG product, or activated PEG derivatives, that are crucial ingredients in the art of PEGylation. GMP manufacturing facility for manufacturing ofPEG products is in oper"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/sunbio-com#asg",
      "name": "선바이오(주) ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/sunbio-com",
      "isPartOf": {
        "@id": "http://www.sunbio.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}